The UMASS CFAR Molecular Biology Core (Core E) serves the research needs of multiple independent investigators conducting HIV/AIDS research at the University of Massachusetts Medical School (UMASS). Based on the NIH CFAR Program goals and objectives, Core E provides essential molecular biology reagents, services, facilities, training and technical expertise in support of basic and clinical HIV/AIDS research programs. Core E also provides added value to the UMASS CFAR and its members by supporting technology development, educational initiatives, and outreach activities that cannot be easily provided through standard research grants. Lastly, Core E continues to foster collaboration and communication between basic and clinical HIV/AIDS investigators at UMASS. Core E Functions Include: * Operation of a Discounted Custom Oligonucleotide Synthesis Service * Operation and Maintenance of a Shared CFAR/PMM DNA Fragment Analysis Facility Operation and Majntenance of CFAR-dedicated HIV- and SIV-specific Primer Libraries * Operation and Maintenance of a CFAR-dedicated DNA Plasmid Repository * Operation and Maintenance of a CFAR-dedicated Surface Plasmon Resonance Facility * Operation and Maintenance of a CFAR-dedicated Real-Time [TAQMAN?] PCR Analysis Service * Operation and Maintenance of a CFAR-dedicated Discounted Reagent Program * Maintenance of a CFAR-dedicated Molecular Biology and Bioinformatics Technical Support Resource * Maintenance of the UMASS CFAR-dedicated WebPages on the Official UMASSMED Website Core E operations, services, facilities, and other activities are structured to ensure that all basic and clinical HIV/AIDS research programs at UMASS derive maximum benefit from CFAR Program resources. During the past period of funding, Core E has proven to be a vital and productive component of the UMASS CFAR and helped raise the visibility of the CFAR Program on the UMASS Medical campus. Moreover, Core E has established itself as a valuable scientific and technical resource within the UMASS research community. During the next period of funding, Core E will continue to demonstrate its steadfast commitment to supporting new and existing HIV/AIDS research programs, HIV/AIDS translational research efforts, CFAR Developmental Projects, technical training and assistance, educational initiatives, scientific mentoring, and HIV/AIDS-related outreach activities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI042845-14S1
Application #
8440953
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
14
Fiscal Year
2012
Total Cost
$245,129
Indirect Cost
$97,461
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Gonzalez-Perez, Maria Paz; Peters, Paul J; O'Connell, Olivia et al. (2017) Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol 91:
Ambade, Aditya; Satishchandran, Abhishek; Szabo, Gyongyi (2016) Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1? activation. Sci Rep 6:21340
Peters, Paul J; Gonzalez-Perez, Maria Paz; Musich, Thomas et al. (2015) Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes. Retrovirology 12:48
Fouda, Genevieve G; Cunningham, Coleen K; McFarland, Elizabeth J et al. (2015) Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. J Infect Dis 211:508-17
Musich, Thomas; O'Connell, Olivia; Gonzalez-Perez, Maria Paz et al. (2015) HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Retrovirology 12:25
Gibson, Laura; Barysauskas, Constance M; McManus, Margaret et al. (2015) Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol 35:289-301
Greenough, Thomas C; Straubhaar, Juerg R; Kamga, Larisa et al. (2015) A Gene Expression Signature That Correlates with CD8+ T Cell Expansion in Acute EBV Infection. J Immunol 195:4185-97
Brehm, Michael A; Wiles, Michael V; Greiner, Dale L et al. (2014) Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods 410:3-17
Luzuriaga, Katherine; Tabak, Barbara; Garber, Manuel et al. (2014) HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. J Infect Dis 210:1529-38
Foulkes-Murzycki, Jennifer E; Rosi, Christina; Kurt Yilmaz, Nese et al. (2013) Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease. ACS Chem Biol 8:513-8

Showing the most recent 10 out of 122 publications